drug
as of 2026-07-01Sodium nitroprusside
sodium nitroprussideSodium Nitroprusside
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Beth Israel Deaconess Medical Center
3 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
3
Sodium Nitroprusside in Early Course Schizophrenia
NCT04986072Phase 2Terminated
A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia
NCT02164981Phase 2Completed
Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia
NCT01548612Phase 2Completed
KOLs & investigators
4
Maurizio Fava, MDKOL score 8
Paulo Lizano, MD, PhDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication
indication
indication
KOL
Maurizio Fava, MD
personKOL score 8
Paulo Lizano, MD, PhD
personKOL score 5
Roy Perlis, MD MSc
personKOL score —
Jaime EC Hallak, Doctor
personKOL score —